Purchase of medicine with active substance bevacizumab AI

TEDAS your procurement assistant

Ask a question about this procurement

t

Attention: This analysis is based on a summary of the submitted procurement documents (Procurement Passport, Form 1, Form 3, Price Offer Form, and Technical Specification). More detailed information may be available in missing annexes (e.g., HAD Annex 2).

Object of Procurement

  • What is being procured: Medicine with active substance bevacizumab (purchase).
  • Main technical requirements, characteristics:
    • ATC code: L01FG01.
    • Product: Bevacizumab biooriginal inf conc 25mg/ml 4ml.
    • Offered form: vial.
      *…
       
      To see full summary, please log in or register.
t

👋 Hello! I am TEDAS – your procurement assistant 💼✨

What would you like to know about this procurement?

Note: This is preliminary information. For accuracy, please review all procurement documents.
Ask your questions here...

297985_ESPD_v2.0_laiendatud.xml

297985_hankepass_taiendavate_selgitustega.pdf

297985_hindamiskriteeriumid.pdf

297985_vastavustingimused.pdf

297985.zip

HAD Lisa 1 - Tehniline kirjeldus.docx

HAD_Lisa_2_Hankelepingu vorm.doc

HAD_uldosa_Ravimi, toimeainega tenekteplaas ja bevatsizumab, ost.doc

Vorm_1_Hankemenetluses_osalemise avaldus_.doc

Vorm_2_Volikiri.doc

Vorm_3_Volitus_ühispakkujad.doc

Vorm_4_ Hinnapakkumuse vorm.xlsx

Ready to get started?

Subscribe and enjoy all the benefits every day!